Skip to main content

Advertisement

Log in

Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Interleukin-10 (IL-10) is a pleiotropic immunosuppressive and immunostimulatory cytokine. In autoimmune diabetes of the nonobese diabetic (NOD) mouse, IL-10 has exhibited paradoxical effects. Systemic IL-10 expression prevented or delayed diabetes onset in NOD mice while local expression of IL-10 did not. As antigen-presenting cells (APCs) play a central role in the generation of primary T cell responses, the direct role of this gene in pancreatic beta (β) cell is not clear. The effects of IL-10 on the protection of β cells in vitro were examined. In the present study, we examined the effects of adenovirus vector-mediated murine IL-10 (mIL-10) gene transfer to islet cell line RINm5F cells in vitro and to explore if IL-10 overexpression may prevent cytokine-mediated cytotoxicity. We had established the recombinant adenovirus vector containing mIL-10 genes (Ad-mIL-10) successfully. After infection of Ad-mIL-10, both mRNA and protein were expressed in RINm5F cells. Moreover, RINm5F cells secreted IL-10 protein into culture medium. Ad-mIL-10 prevented IL-1β-mediated nitric oxide production from β cells in vitro as well as the suppression of β cells function as determined by glucose-stimulated insulin production. Furthermore, Ad-mIL-10 gene transfer led to a profound reduction of Fas-expressing β cells and caspase-3 activity which were induced by IL-1β and the apoptotic rates of Ad-mIL-10 group were decreased. These findings show that IL-10 gene transfer to β cells may be beneficial in maintaining cells function, protecting islet cells from apoptosis—mediated by factors, which showed the potential therapy for type 1 diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358(9277):221–229

    Article  CAS  PubMed  Google Scholar 

  2. Falcone M, Sarvetnick N (1999) The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Clin Immunol 90(1):2–9

    Article  CAS  PubMed  Google Scholar 

  3. Rabinovitch A, Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55(8):1139–1149

    Article  CAS  PubMed  Google Scholar 

  4. Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T et al (2003) Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52(3):708–716

    Article  CAS  PubMed  Google Scholar 

  5. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170(6):2081–2095

    Article  CAS  PubMed  Google Scholar 

  6. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765

    Article  CAS  PubMed  Google Scholar 

  7. Teros T, Hakala R, Ylinen L, Liukas A, Arvilommi P, Sainio-Pollanen S et al (2000) Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis. Pancreas 20(2):191–196

    Article  CAS  PubMed  Google Scholar 

  8. Szelachowska M, Kretowski A, Kinalska I (1998) Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I. Horm Metab Res 30(8):526–530

    Article  CAS  PubMed  Google Scholar 

  9. Pennline KJ, Roque-Gaffney E, Monahan M (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71(2):169–175

    Article  CAS  PubMed  Google Scholar 

  10. Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P et al (1997) A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 158(9):4507–4513

    CAS  PubMed  Google Scholar 

  11. Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A et al (2001) Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci USA 98(24):13913–13918

    Article  CAS  PubMed  Google Scholar 

  12. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A et al (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48(4):745–753

    Article  CAS  PubMed  Google Scholar 

  13. Csete ME, Benhamou PY, Drazan KE, Wu L, McIntee DF, Afra R et al (1995) Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59(2):263–268

    CAS  PubMed  Google Scholar 

  14. Kuttler B, Wanka H, Kloting N, Gerstmayer B, Volk HD, Sawitzki B et al (2007) Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats. J Cell Mol Med 11(4):868–880

    Article  CAS  PubMed  Google Scholar 

  15. Holohan C, Szegezdi E, Ritter T, O’Brien T, Samali A (2008) Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J Cell Mol Med 12(2):591–606

    Article  CAS  PubMed  Google Scholar 

  16. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50(5):909–920

    Article  CAS  PubMed  Google Scholar 

  17. Marselli L, Dotta F, Piro S, Santangelo C, Masini M, Lupi R et al (2001) Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86(10):4974–4978

    Article  CAS  PubMed  Google Scholar 

  18. Souza KL, Gurgul-Convey E, Elsner M, Lenzen S (2008) Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol 197(1):139–150

    Article  CAS  PubMed  Google Scholar 

  19. Storling J, Binzer J, Andersson AK, Zullig RA, Tonnesen M, Lehmann R et al (2005) Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 48(10):2039–2050

    Article  CAS  PubMed  Google Scholar 

  20. Veluthakal R, Amin R, Kowluru A (2004) Interleukin-1 beta induces posttranslational carboxymethylation and alterations in subnuclear distribution of lamin B in insulin-secreting RINm5F cells. Am J Physiol 287(4):C1152–C1162

    Article  CAS  Google Scholar 

  21. Zumsteg U, Frigerio S, Hollander GA (2000) Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage. Diabetes 49(1):39–47

    Article  CAS  PubMed  Google Scholar 

  22. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS et al (1995) Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27(6):3271–3275

    CAS  PubMed  Google Scholar 

  23. Darwiche R, Chong MM, Santamaria P, Thomas HE, Kay TW (2003) Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice. J Immunol 170(12):6292–6297

    CAS  PubMed  Google Scholar 

  24. Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R et al (1996) Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood 88(7):2549–2558

    CAS  PubMed  Google Scholar 

  25. Zhou JH, Broussard SR, Strle K, Freund GG, Johnson RW, Dantzer R et al (2001) IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase. J Immunol 167(8):4436–4442

    CAS  PubMed  Google Scholar 

  26. Wang Y, Lou S (2001) Direct protective effect of interleukin-10 on articular chondrocytes in vitro. Chin Med J 114(7):723–725

    CAS  PubMed  Google Scholar 

  27. Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K (2006) IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression. Am J Physiol Gastrointest Liver Physiol 291(5):G820–G829

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by a grant from the Natural Science Foundation of Shandong province (grant no: Y2008C50). We appreciated Prof. Bing Luo and Dr. Zhi-hong Chen for their excellent technique assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tang Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, AJ., Zhu, W., Tian, F. et al. Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine. Mol Cell Biochem 344, 163–171 (2010). https://doi.org/10.1007/s11010-010-0539-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0539-x

Keywords

Navigation